NPI: 1558575746 · ORANGE, CA 92868 · General Acute Care Hospital · NPI assigned 05/09/2007
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS) |
| NPI Enumeration Date | 05/09/2007 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 312,906 | $8.43M |
| 2019 | 333,868 | $10.64M |
| 2020 | 376,910 | $10.94M |
| 2021 | 372,294 | $8.43M |
| 2022 | 364,191 | $8.53M |
| 2023 | 355,668 | $9.77M |
| 2024 | 241,984 | $9.21M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 57,838 | 4,006 | $14.13M |
| 78815 | Positron emission tomography (PET) for limited area imaging | 2,724 | 2,591 | $4.42M |
| J9306 | Injection, pertuzumab, 1 mg | 847 | 569 | $2.49M |
| 0450 | Emergency room services | 131,678 | 113,327 | $2.10M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 44,361 | 36,732 | $2.03M |
| J0897 | Injection, denosumab, 1 mg | 2,188 | 1,829 | $1.87M |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 1,076 | 680 | $1.83M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8,315 | 7,566 | $1.59M |
| 96375 | Therapeutic injection; each additional sequential IV push | 44,660 | 30,957 | $1.43M |
| Z7502 | 33,674 | 33,390 | $1.27M | |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 25,672 | 15,661 | $1.13M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 33,509 | 7,109 | $1.05M |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 11,543 | 11,230 | $902K |
| J2505 | Injection, pegfilgrastim, 6 mg | 547 | 360 | $860K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 15,692 | 9,454 | $749K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2,678 | 2,541 | $713K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 4,892 | 1,138 | $684K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 42,870 | 37,691 | $678K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6,549 | 6,010 | $652K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 110,217 | 91,764 | $641K |
| Q5114 | Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg | 818 | 473 | $621K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 11,686 | 8,884 | $603K |
| 80053 | Comprehensive metabolic panel | 65,737 | 57,556 | $593K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 28,844 | 21,203 | $586K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 6,266 | 5,744 | $579K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7,996 | 7,105 | $570K |
| 70450 | Computed tomography, head or brain; without contrast material | 9,064 | 8,340 | $563K |
| 93975 | 3,589 | 3,346 | $558K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4,685 | 4,390 | $551K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3,097 | 3,066 | $547K |
| 96361 | Intravenous infusion, hydration; each additional hour | 17,098 | 13,043 | $526K |
| J3490 | Unclassified drugs | 97,481 | 33,124 | $522K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 8,412 | 7,292 | $483K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 2,135 | 1,519 | $471K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 10,261 | 8,867 | $463K |
| 59025 | Fetal non-stress test | 20,283 | 5,718 | $444K |
| 99199 | Unlisted special service, procedure or report | 7,051 | 6,318 | $414K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,506 | 1,359 | $356K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,719 | 2,281 | $343K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,247 | 2,102 | $342K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 349 | 223 | $337K |
| 76830 | Ultrasound, transvaginal | 5,978 | 5,734 | $332K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,802 | 1,649 | $316K |
| 97750 | 5,210 | 2,726 | $312K | |
| 76801 | 5,872 | 5,138 | $312K | |
| Z9725 | 7,160 | 7,092 | $308K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 6,729 | 6,210 | $294K |
| G0378 | Hospital observation service, per hour | 1,331 | 939 | $289K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 10,314 | 5,557 | $288K |
| 71045 | Radiologic examination, chest; single view | 28,415 | 25,200 | $264K |
| 80048 | Basic metabolic panel (calcium, ionized) | 54,494 | 40,835 | $257K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,927 | 1,653 | $251K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 5,661 | 4,860 | $248K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,562 | 4,807 | $240K |
| 0760 | 18,228 | 13,180 | $239K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 6,629 | 6,367 | $227K |
| 93971 | 2,045 | 1,918 | $203K | |
| 77066 | Tomosynthesis, mammo | 1,550 | 1,521 | $201K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 5,023 | 3,231 | $189K |
| 83690 | 36,397 | 31,725 | $182K | |
| 84484 | 25,457 | 19,891 | $174K | |
| 97139 | 8,239 | 979 | $173K | |
| 77334 | 1,019 | 602 | $172K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,935 | 1,787 | $172K |
| 96417 | 4,215 | 2,571 | $170K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3,667 | 3,057 | $166K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,092 | 4,732 | $164K |
| 77412 | 3,510 | 327 | $163K | |
| 87631 | 3,242 | 3,018 | $160K | |
| 83880 | 7,381 | 6,405 | $158K | |
| J2997 | Injection, alteplase recombinant, 1 mg | 4,496 | 248 | $157K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14,656 | 12,953 | $137K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 4,670 | 4,376 | $137K |
| 93325 | 1,105 | 1,051 | $133K | |
| 76642 | 2,275 | 2,194 | $133K | |
| J1756 | Injection, iron sucrose, 1 mg | 7,550 | 3,053 | $130K |
| J9271 | Injection, pembrolizumab, 1 mg | 29 | 24 | $117K |
| 96367 | 3,737 | 2,343 | $116K | |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 7,263 | 6,582 | $111K |
| 77336 | 2,092 | 880 | $111K | |
| 77065 | Tomosynthesis, mammo | 1,183 | 1,089 | $109K |
| 77386 | 448 | 29 | $106K | |
| 71046 | Radiologic examination, chest; 2 views | 6,505 | 6,164 | $103K |
| 76770 | 1,771 | 1,674 | $100K | |
| 83970 | 2,759 | 2,281 | $97K | |
| C1769 | Guide wire | 2,610 | 1,929 | $95K |
| J2501 | Injection, paricalcitol, 1 mcg | 29,746 | 2,396 | $89K |
| 96376 | 17,914 | 10,549 | $86K | |
| 84443 | Thyroid stimulating hormone (TSH) | 7,344 | 6,765 | $86K |
| 80061 | Lipid panel | 7,331 | 7,117 | $86K |
| J1453 | Injection, fosaprepitant, 1 mg | 1,754 | 1,021 | $85K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 16,038 | 14,157 | $84K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 5,790 | 3,598 | $82K |
| 81001 | 37,034 | 33,096 | $82K | |
| Q5120 | Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg | 104 | 68 | $81K |
| 84702 | 18,190 | 16,084 | $78K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 4,658 | 2,537 | $77K |
| 85027 | 15,528 | 8,766 | $75K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 28,382 | 17,282 | $75K |
| J1644 | Injection, heparin sodium, per 1000 units | 31,915 | 4,565 | $74K |
| 90715 | 2,605 | 2,450 | $74K | |
| 87040 | 10,038 | 5,636 | $74K | |
| 80076 | 18,393 | 15,129 | $73K | |
| 96415 | 2,311 | 1,457 | $73K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 8,652 | 8,236 | $70K |
| 36902 | 132 | 89 | $68K | |
| 82330 | 7,788 | 6,510 | $68K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 37,884 | 26,292 | $68K |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 98 | 38 | $67K |
| 71250 | 768 | 749 | $64K | |
| 73562 | 3,446 | 3,036 | $64K | |
| 73630 | 3,232 | 2,909 | $59K | |
| 93970 | 309 | 291 | $57K | |
| 82947 | 32,119 | 21,673 | $55K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 506 | 389 | $55K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,004 | 1,919 | $55K |
| 0160 | 6,702 | 3,405 | $55K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 3,201 | 2,836 | $54K |
| 82805 | 3,677 | 2,941 | $53K | |
| 84145 | 3,073 | 2,618 | $49K | |
| 76536 | 910 | 899 | $49K | |
| 81025 | 15,967 | 14,840 | $49K | |
| 86923 | 1,703 | 1,237 | $48K | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,629 | 2,904 | $48K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 416 | 388 | $48K |
| 81003 | 32,658 | 29,880 | $46K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 1,033 | 771 | $45K |
| 95811 | 186 | 185 | $43K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 808 | 735 | $43K |
| 73610 | 2,399 | 2,231 | $42K | |
| 82803 | 3,869 | 3,536 | $42K | |
| 72100 | 1,921 | 1,813 | $41K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 1,431 | 1,424 | $41K |
| 73130 | 2,238 | 2,033 | $40K | |
| 73030 | 2,326 | 2,100 | $40K | |
| 97010 | 1,347 | 229 | $40K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,912 | 1,479 | $39K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,955 | 932 | $39K |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 137 | 136 | $39K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,908 | 2,588 | $39K |
| 87077 | 6,070 | 5,540 | $38K | |
| Z7500 | 1,113 | 662 | $38K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 9,097 | 4,345 | $37K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 929 | 673 | $37K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 263 | 257 | $36K |
| 77080 | 1,104 | 1,095 | $35K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,986 | 1,492 | $34K |
| J9070 | Cyclophosphamide, 100 mg | 208 | 87 | $34K |
| J0606 | Injection, etelcalcetide, 0.1 mg | 764 | 55 | $34K |
| J7030 | Infusion, normal saline solution , 1000 cc | 5,263 | 4,049 | $34K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 17,947 | 14,830 | $32K |
| J0185 | Injection, aprepitant, 1 mg | 265 | 203 | $32K |
| 83735 | 8,716 | 5,881 | $31K | |
| 99153 | Mod sedat endo service >5yrs | 1,145 | 855 | $31K |
| 87186 | 5,045 | 4,595 | $30K | |
| 76813 | 378 | 378 | $29K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 11,965 | 8,217 | $29K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 12,425 | 8,054 | $29K |
| 93976 | 181 | 178 | $28K | |
| 83550 | 4,050 | 3,278 | $28K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 10,354 | 5,404 | $27K |
| 86141 | 3,467 | 2,833 | $26K | |
| Z6004 | 12 | 12 | $26K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,097 | 913 | $26K |
| 77300 | 253 | 208 | $26K | |
| J2704 | Injection, propofol, 10 mg | 7,217 | 5,807 | $25K |
| 36430 | 189 | 120 | $25K | |
| 82728 | 3,588 | 2,814 | $25K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 6,767 | 4,880 | $24K |
| 85610 | 10,276 | 8,407 | $24K | |
| Z7610 | 5,982 | 3,965 | $24K | |
| 74018 | 1,594 | 1,462 | $24K | |
| 83540 | 4,235 | 3,512 | $24K | |
| 86901 | 11,759 | 9,903 | $24K | |
| 82375 | 3,606 | 2,896 | $23K | |
| 83605 | 4,037 | 3,177 | $23K | |
| 86803 | 1,717 | 1,599 | $23K | |
| 76937 | 1,962 | 1,436 | $23K | |
| 86900 | 11,766 | 9,907 | $23K | |
| 88720 | 4,400 | 4,386 | $23K | |
| 85379 | 3,229 | 2,844 | $22K | |
| 87081 | 2,358 | 2,084 | $22K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 11,958 | 8,260 | $22K |
| 82570 | 5,349 | 4,396 | $22K | |
| 84100 | 7,348 | 4,976 | $22K | |
| 97165 | 806 | 581 | $21K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 10,095 | 8,059 | $21K |
| 99152 | 1,232 | 949 | $21K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 382 | 345 | $21K |
| 72125 | Computed tomography, cervical spine; without contrast material | 228 | 212 | $21K |
| 73110 | 1,117 | 1,035 | $20K | |
| 73502 | 721 | 653 | $19K | |
| 88307 | 438 | 353 | $18K | |
| 85730 | 5,369 | 4,367 | $18K | |
| J7050 | Infusion, normal saline solution, 250 cc | 4,200 | 2,094 | $18K |
| 96402 | 1,318 | 1,071 | $17K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 285 | 284 | $17K |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 28 | 14 | $17K |
| 72040 | 667 | 636 | $17K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 504 | 503 | $16K |
| 86850 | 7,526 | 6,078 | $16K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 7,599 | 5,981 | $16K |
| 10060 | 1,182 | 1,120 | $15K | |
| J2060 | Injection, lorazepam, 2 mg | 7,312 | 5,059 | $15K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,398 | 1,337 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,403 | 1,341 | $15K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 3,493 | 1,578 | $14K |
| 84550 | 4,764 | 3,595 | $14K | |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | 242 | 157 | $14K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 689 | 686 | $14K |
| 97014 | 823 | 321 | $14K | |
| 77280 | 181 | 159 | $14K | |
| 83050 | 3,609 | 2,896 | $13K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 335 | 315 | $13K |
| A4217 | Sterile water/saline, 500 ml | 2,185 | 1,784 | $13K |
| 90834 | Psychotherapy, 45 minutes with patient | 202 | 110 | $13K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,062 | 2,778 | $13K |
| J1815 | Injection, insulin, per 5 units | 5,570 | 2,627 | $13K |
| 82043 | 2,444 | 2,403 | $13K | |
| J9171 | Injection, docetaxel, 1 mg | 157 | 104 | $12K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,413 | 1,129 | $12K |
| 87340 | 1,472 | 1,259 | $11K | |
| 88304 | 1,638 | 1,397 | $11K | |
| 96523 | 1,706 | 1,363 | $11K | |
| 82550 | 3,237 | 2,599 | $11K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 5,400 | 4,362 | $11K |
| J3370 | Injection, vancomycin hcl, 500 mg | 2,563 | 1,499 | $11K |
| 73590 | 672 | 628 | $11K | |
| 0270 | 100,279 | 37,052 | $11K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,141 | 5,020 | $10K |
| 80069 | 1,579 | 1,108 | $10K | |
| 49083 | 286 | 121 | $10K | |
| 77001 | 270 | 177 | $10K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,901 | 1,633 | $10K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 28 | 27 | $10K |
| 77290 | 72 | 64 | $9K | |
| 80197 | 1,678 | 982 | $9K | |
| J9045 | Injection, carboplatin, 50 mg | 381 | 252 | $9K |
| 77295 | 31 | 26 | $9K | |
| 84156 | 3,555 | 2,705 | $9K | |
| 99401 | 524 | 457 | $8K | |
| 84132 | 10,504 | 7,857 | $8K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 1,774 | 1,108 | $8K |
| 97162 | 1,447 | 1,273 | $8K | |
| 76870 | 200 | 187 | $8K | |
| 73080 | 373 | 343 | $8K | |
| 77417 | 711 | 121 | $7K | |
| 47562 | 44 | 43 | $7K | |
| 85007 | 4,612 | 3,219 | $7K | |
| 76825 | 360 | 349 | $7K | |
| 84703 | 4,185 | 3,933 | $7K | |
| 87070 | 1,693 | 1,469 | $7K | |
| 0360 | 3,101 | 2,678 | $7K | |
| 83615 | 2,546 | 1,615 | $7K | |
| 87210 | 1,991 | 1,717 | $7K | |
| 84439 | 984 | 892 | $7K | |
| 96411 | 373 | 229 | $7K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,104 | 966 | $7K |
| 36415 | Collection of venous blood by venipuncture | 6,744 | 4,161 | $6K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 167 | 162 | $6K |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 111 | 78 | $6K |
| 82731 | 328 | 303 | $6K | |
| 96156 | 363 | 361 | $6K | |
| 84460 | 1,379 | 1,124 | $6K | |
| 82040 | 1,688 | 1,513 | $5K | |
| 84295 | 7,319 | 6,344 | $5K | |
| 84520 | 1,979 | 1,522 | $5K | |
| 93880 | 39 | 38 | $5K | |
| 87205 | 2,103 | 1,703 | $5K | |
| 86920 | 282 | 238 | $5K | |
| 0710 | 6,756 | 5,654 | $5K | |
| 76820 | 660 | 331 | $5K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,844 | 980 | $5K |
| 12001 | 434 | 428 | $5K | |
| 85652 | 2,354 | 2,027 | $5K | |
| 90686 | 209 | 181 | $5K | |
| 82435 | 7,234 | 6,278 | $5K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,262 | 989 | $4K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 964 | 809 | $4K |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 1,265 | 1,005 | $4K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 17 | 15 | $4K |
| 87075 | 923 | 783 | $4K | |
| 88342 | 437 | 381 | $4K | |
| 70496 | 26 | 25 | $4K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 586 | 520 | $4K |
| 10061 | 185 | 179 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 732 | 702 | $4K |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | 54 | 53 | $4K |
| 0250 | 11,440 | 4,893 | $4K | |
| 87799 | 265 | 217 | $4K | |
| 77049 | 12 | 12 | $4K | |
| 85018 | 7,936 | 6,570 | $4K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 1,043 | 888 | $3K |
| 86706 | 381 | 278 | $3K | |
| J1940 | Injection, furosemide, up to 20 mg | 1,646 | 1,032 | $3K |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 61 | 61 | $3K |
| 87147 | 1,168 | 1,047 | $3K | |
| 82465 | 1,142 | 771 | $3K | |
| 97802 | 56 | 55 | $3K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,236 | 923 | $3K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 26 | 25 | $3K |
| 70486 | 28 | 28 | $3K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,455 | 2,841 | $3K |
| 84480 | 283 | 258 | $3K | |
| 87430 | 636 | 614 | $3K | |
| 99215 | Prolong outpt/office vis | 32 | 32 | $3K |
| 97116 | 123 | 86 | $2K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 87 | 83 | $2K |
| 93017 | 59 | 58 | $2K | |
| 0761 | 5,259 | 3,908 | $2K | |
| 82553 | 446 | 355 | $2K | |
| 82140 | 262 | 166 | $2K | |
| 96401 | 161 | 55 | $2K | |
| J9267 | Injection, paclitaxel, 1 mg | 137 | 66 | $2K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 13 | 12 | $2K |
| 71020 | 113 | 111 | $2K | |
| 93320 | 52 | 49 | $2K | |
| H1003 | Prenatal care, at-risk enhanced service; education | 66 | 66 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 429 | 306 | $2K |
| J8540 | Dexamethasone, oral, 0.25 mg | 2,292 | 1,301 | $2K |
| 82150 | 430 | 395 | $2K | |
| 95806 | 33 | 33 | $2K | |
| J2720 | Injection, protamine sulfate, per 10 mg | 500 | 345 | $2K |
| 74181 | 12 | 12 | $2K | |
| 87493 | 89 | 79 | $2K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 28 | 13 | $2K |
| 76827 | 126 | 126 | $2K | |
| 90747 | 16 | 16 | $2K | |
| 80047 | 296 | 292 | $2K | |
| 87497 | 171 | 139 | $2K | |
| 71010 | 176 | 172 | $2K | |
| G0204 | Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 23 | 23 | $2K |
| J1630 | Injection, haloperidol, up to 5 mg | 3,043 | 2,250 | $2K |
| 73140 | 160 | 154 | $2K | |
| 72141 | 13 | 13 | $2K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 509 | 395 | $2K |
| 29125 | 463 | 442 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 666 | 475 | $2K |
| 41899 | Unlisted procedure, dentoalveolar structures | 54 | 52 | $2K |
| 88341 | 26 | 26 | $2K | |
| 85045 | 592 | 465 | $1K | |
| 70498 | 14 | 13 | $1K | |
| 29515 | 291 | 283 | $1K | |
| J3480 | Injection, potassium chloride, per 2 meq | 859 | 504 | $1K |
| C1760 | Closure device, vascular (implantable/insertable) | 12 | 12 | $1K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 231 | 173 | $1K |
| J9190 | Injection, fluorouracil, 500 mg | 135 | 61 | $1K |
| 0272 | 6,997 | 4,588 | $1K | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 200 | 103 | $1K |
| 80179 | 65 | 64 | $1K | |
| C1893 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away | 638 | 457 | $1K |
| 72170 | 163 | 156 | $1K | |
| 90688 | 40 | 40 | $1K | |
| 80143 | 61 | 60 | $1K | |
| G0206 | Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral | 14 | 14 | $1K |
| 86902 | 70 | 51 | $987.18 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 324 | 213 | $986.90 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 269 | 269 | $946.31 |
| 0258 | 7,473 | 4,254 | $921.19 | |
| 96368 | 82 | 63 | $918.99 | |
| J1953 | Injection, levetiracetam, 10 mg | 108 | 66 | $853.70 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 88 | 49 | $829.14 |
| 73090 | 54 | 51 | $822.11 | |
| 92610 | 13 | 13 | $815.84 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 9,541 | 613 | $797.53 |
| 77331 | 27 | 13 | $787.78 | |
| 99499 | 15 | 14 | $744.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 212 | 159 | $670.07 |
| 85014 | 377 | 352 | $665.01 | |
| 0637 | 3,371 | 1,629 | $661.67 | |
| J0456 | Injection, azithromycin, 500 mg | 318 | 191 | $656.62 |
| 74022 | 42 | 36 | $640.57 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4,093 | 3,909 | $633.98 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 13 | 13 | $564.98 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 130 | 101 | $551.19 |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion | 19 | 12 | $550.60 |
| 90656 | 22 | 22 | $535.51 | |
| 86140 | 173 | 138 | $531.90 | |
| 97803 | 40 | 39 | $529.70 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 66 | 37 | $499.73 |
| 84540 | 142 | 109 | $480.44 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,923 | 1,488 | $434.62 |
| 93350 | 12 | 12 | $430.01 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 307 | 296 | $412.64 |
| 82565 | 263 | 252 | $381.96 | |
| 93798 | 50 | 12 | $355.08 | |
| 82270 | 107 | 107 | $347.70 | |
| 84436 | 79 | 79 | $344.83 | |
| C1789 | Prosthesis, breast (implantable) | 12 | 12 | $334.43 |
| 73552 | 13 | 12 | $307.26 | |
| H2000 | Comprehensive multidisciplinary evaluation | 12 | 12 | $306.15 |
| J3411 | Injection, thiamine hcl, 100 mg | 38 | 29 | $300.02 |
| 74000 | 31 | 31 | $290.34 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 162 | 131 | $288.22 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 57 | 55 | $278.93 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 182 | 179 | $277.29 |
| 73560 | 16 | 14 | $276.36 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 284 | 230 | $265.94 |
| J3535 | Drug administered through a metered dose inhaler | 298 | 275 | $259.14 |
| 88312 | 32 | 28 | $249.94 | |
| J1956 | Injection, levofloxacin, 250 mg | 71 | 50 | $237.06 |
| J1836 | Injection, metronidazole, 10 mg | 15 | 12 | $235.88 |
| A4648 | Tissue marker, implantable, any type, each | 29 | 28 | $226.26 |
| 73060 | 14 | 13 | $209.40 | |
| 84153 | 13 | 13 | $180.01 | |
| 80306 | 17 | 17 | $175.56 | |
| 99070 | 997 | 445 | $170.27 | |
| 84450 | 63 | 59 | $161.70 | |
| S9452 | Nutrition classes, non-physician provider, per session | 12 | 12 | $141.24 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 139 | 111 | $139.16 |
| 36600 | 43 | 43 | $124.74 | |
| 82310 | 235 | 192 | $90.72 | |
| 86780 | 17 | 15 | $89.56 | |
| 82607 | 25 | 25 | $81.22 | |
| 0370 | 537 | 365 | $73.45 | |
| 87899 | 40 | 25 | $72.15 | |
| 84075 | 231 | 153 | $71.70 | |
| 0391 | 372 | 292 | $68.20 | |
| 94664 | 131 | 126 | $63.74 | |
| 59425 | 39 | 27 | $60.48 | |
| 87045 | 16 | 13 | $59.47 | |
| 88300 | 50 | 38 | $59.05 | |
| 81050 | 53 | 53 | $55.16 | |
| 29130 | 13 | 13 | $54.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 14,464 | 12,107 | $49.78 |
| 77062 | 468 | 447 | $49.32 | |
| 87324 | 12 | 12 | $43.15 | |
| 87015 | 17 | 12 | $42.68 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 1,386 | 1,105 | $38.70 |
| 87046 | 16 | 13 | $31.45 | |
| 87102 | 13 | 13 | $26.81 | |
| 89051 | 28 | 24 | $24.37 | |
| 77061 | 163 | 152 | $23.67 | |
| 84155 | 127 | 123 | $17.75 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 125 | 70 | $17.51 |
| 84466 | 27 | 27 | $11.01 | |
| A9270 | Non-covered item or service | 5,831 | 1,530 | $10.33 |
| 82077 | 44 | 39 | $8.40 | |
| S0074 | Injection, cefotetan disodium, 500 mg | 14 | 12 | $7.58 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 17 | 12 | $7.23 |
| 64450 | 12 | 12 | $7.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 64 | 59 | $4.97 |
| S0028 | Injection, famotidine, 20 mg | 2,584 | 1,288 | $4.95 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 12 | 12 | $0.68 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 93 | 84 | $0.01 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 143 | 121 | $0.01 |
| 0331 | 40 | 22 | $0.00 | |
| 0307 | 387 | 344 | $0.00 | |
| 0610 | 30 | 27 | $0.00 | |
| 0636 | 1,877 | 678 | $0.00 | |
| 0310 | 129 | 74 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 56 | 53 | $0.00 |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 768 | 94 | $0.00 |
| 0335 | 299 | 77 | $0.00 | |
| 0404 | 38 | 38 | $0.00 | |
| 0949 | 551 | 168 | $0.00 | |
| 0401 | 86 | 43 | $0.00 | |
| 97166 | 55 | 55 | $0.00 | |
| 0305 | 379 | 186 | $0.00 | |
| 0372 | 38 | 16 | $0.00 | |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 12 | 12 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 27 | 27 | $0.00 |
| 0922 | 71 | 70 | $0.00 | |
| 80050 | General health panel | 128 | 79 | $0.00 |
| 0352 | 218 | 177 | $0.00 | |
| 0324 | 462 | 386 | $0.00 | |
| 0306 | 1,557 | 941 | $0.00 | |
| Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) | 23 | 16 | $0.00 |
| 0301 | 5,052 | 941 | $0.00 | |
| 0611 | 13 | 12 | $0.00 | |
| 0420 | 186 | 47 | $0.00 | |
| 0612 | Calcium glucon (wg critical) | 15 | 13 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 15 | 14 | $0.00 |
| 0410 | 56 | 19 | $0.00 | |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 12 | 12 | $0.00 |
| A4657 | Syringe, with or without needle, each | 405 | 22 | $0.00 |
| 0300 | 2,171 | 895 | $0.00 | |
| 0361 | 454 | 389 | $0.00 | |
| 0260 | 340 | 58 | $0.00 | |
| 0510 | 261 | 222 | $0.00 | |
| 84112 | 33 | 32 | $0.00 | |
| 0403 | 94 | 46 | $0.00 | |
| 0320 | 301 | 206 | $0.00 | |
| 0351 | 88 | 73 | $0.00 | |
| 0302 | 191 | 105 | $0.00 | |
| 0489 | 33 | 27 | $0.00 | |
| 0634 | 293 | 51 | $0.00 | |
| 0424 | 23 | 13 | $0.00 | |
| 0402 | 995 | 573 | $0.00 | |
| 0349 | 34 | 34 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 21 | 21 | $0.00 |
| 0333 | 212 | 13 | $0.00 | |
| 0762 | 31 | 14 | $0.00 | |
| 0343 | 15 | 13 | $0.00 | |
| 0278 | 154 | 61 | $0.00 | |
| 0390 | 31 | 21 | $0.00 |